Lenvatinib for Anaplastic Thyroid Cancer

BACKGROUND: Lenvatinib has been approved by regulatory agencies in Japan, the United States, and the European Union for treatment of radioiodine-refractory differentiated thyroid cancer (RR-DTC). Thyroid cancer, however, is a clinically diverse disease that includes anaplastic thyroid cancer (ATC),...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Tahara, Makoto, Kiyota, Naomi, Yamazaki, Tomoko, Chayahara, Naoko, Nakano, Kenji, Inagaki, Lina, Toda, Kazuhisa, Enokida, Tomohiro, Minami, Hironobu, Imamura, Yoshinori, Sasaki, Tatsuya, Suzuki, Takuya, Fujino, Katsuki, Dutcus, Corina E., Takahashi, Shunji
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5331066/
https://ncbi.nlm.nih.gov/pubmed/28299283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00025
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados